Katarina Sjögreen Gleisner
41 – 50 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer
(
- Contribution to journal › Article
-
Mark
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
-
Mark
Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
(
- Contribution to journal › Article
-
Mark
Uncertainty propagation for SPECT/CT-based renal dosimetry in (177)Lu peptide receptor radionuclide therapy.
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in (177)Lu-DOTATATE peptide receptor radionuclide therapy.
(
- Contribution to journal › Article
-
Mark
Long-term retention of 177Lu/177mLu-Dotatate in patients investigated by gamma spectrometry and gamma camera imaging.
(
- Contribution to journal › Article
- 2014
-
Mark
Testis dosimetry in individual patients by combining a small-scale dosimetry model and pharmacokinetic modeling-application of (111)In-Ibritumomab Tiuxetan (Zevalin(®)).
(
- Contribution to journal › Article
- 2013
-
Mark
On the biologically effective dose (BED)-using convolution for calculating the effects of repair: I. Analytical considerations.
(
- Contribution to journal › Article
-
Mark
Dynamic (99m)Tc-MAG3 renography: images for quality control obtained by combining pharmacokinetic modelling, an anthropomorphic computer phantom and Monte Carlo simulated scintillation camera imaging.
(
- Contribution to journal › Article